- Home
- CWD vs HSCS Comparison
CWD vs HSCS Comparison
Compare CWD & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWD
- HSCS
- Stock Information
- Founded
- CWD 2009
- HSCS 2007
- Country
- CWD United States
- HSCS United States
- Employees
- CWD N/A
- HSCS N/A
- Industry
- CWD Real Estate
- HSCS Medical Specialities
- Sector
- CWD Finance
- HSCS Health Care
- Exchange
- CWD Nasdaq
- HSCS Nasdaq
- Market Cap
- CWD 4.5M
- HSCS 3.7M
- IPO Year
- CWD 2023
- HSCS 2022
- Fundamental
- Price
- CWD $3.39
- HSCS $4.16
- Analyst Decision
- CWD
- HSCS Strong Buy
- Analyst Count
- CWD 0
- HSCS 2
- Target Price
- CWD N/A
- HSCS $13.00
- AVG Volume (30 Days)
- CWD 23.9K
- HSCS 143.4K
- Earning Date
- CWD 08-11-2025
- HSCS 07-28-2025
- Dividend Yield
- CWD N/A
- HSCS N/A
- EPS Growth
- CWD N/A
- HSCS N/A
- EPS
- CWD N/A
- HSCS N/A
- Revenue
- CWD $35,429,000.00
- HSCS N/A
- Revenue This Year
- CWD N/A
- HSCS N/A
- Revenue Next Year
- CWD $31.12
- HSCS N/A
- P/E Ratio
- CWD N/A
- HSCS N/A
- Revenue Growth
- CWD N/A
- HSCS 261.17
- 52 Week Low
- CWD $3.00
- HSCS $2.36
- 52 Week High
- CWD $16.96
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- CWD 48.36
- HSCS 52.49
- Support Level
- CWD $3.13
- HSCS $3.57
- Resistance Level
- CWD $3.75
- HSCS $6.47
- Average True Range (ATR)
- CWD 0.30
- HSCS 0.58
- MACD
- CWD 0.05
- HSCS 0.10
- Stochastic Oscillator
- CWD 53.25
- HSCS 21.96
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.